Welcome to Money Morning - Only the News You Can Profit From.

Skip to content

Healthcare - Money Morning - Only the News You Can Proft From.

Premium

Experimental Brain Injury Treatments Could Be Worth Billions

Brain trauma is one tough and expensive field.

Each year brain injuries cost the nation roughly $50 billion. That's half a trillion every decade.

And then there's the human toll….

Brain injuries kill 52,000 people each year, making this the third leading cause of death from injury.

But there's more to this story than the death toll. Another 80,000 people a year in the U.S. survive brain injuries but go on to lead reduced lives.

Luckily, there is hope. Today we're on the verge of saving millions from the suffering brought about by traumatic brain injuries.

These insights also will lead to new treatments for such severe brain diseases as Lou Gehrig's (also known as ALS) and Alzheimer's.

And that's what the Era of Radical Change is all about — seeing friends and family survive things that a few years ago would have killed them.

It's all the result of more than 50 years of exponential growth in high tech and its effect on every aspect of science.

We are now at a tipping point in human history. Cases that once seemed doomed now offer new hope.

Brain Injuries: The Tragedy and the Hope

Unfortunately, this is a story I know all too well. It is one of the reasons why I'm deeply interested in this field.

Nineteen years ago last March, my cousin was killed in an infamous boating accident while his family looked on.

Doctors tried to save him but to no avail. His brain injuries were just too severe.

Now I wonder how my cousin would have done had that very same boat crash happened today.

As it turns out, a similar accident just occurred in our town.

To continue reading, please click here…

Weight Loss Stocks: ARNA, VVUS, and OREX Race to End the Obesity Epidemic

Obesity is considered the most serious health issue in the developed world. Along with growing waistlines also comes ballooning costs.

Across urbanized nations, the economic burden of obesity is estimated to be 10% of total health care costs, with projections continuing to grow as the obesity epidemic spreads.

For investors, that means weight loss stocks are poised to gain.

Here's why.

When it comes to obesity the statistics are staggering.

Currently 35.7% of U.S. adults, or more than one third, is obese. According to the Centers for Disease Control (CDC), that's a giant increase over just ten years ago.

In 2000, not a single U.S. state had an obesity rate of 30% or more. Today, 12 states have crossed that obesity threshold.

The costs attributed to obesity are estimated at $147 billion and rising.

Weight Loss Stocks: ARNA, VVUS and OREX

It is no wonder pharmaceutical companies are racing to fill the void and close the growing gap in treating this mounting epidemic.

Two leaders early in the game include Arena Pharmaceuticals Inc. (NASDAQ: ARNA) and Vivus Inc. (NASDAQ: VVUS) A third California-based company, Orexigen Therapeutics Inc. (NASDAQ: OREX), is also vying for Food and Drug Administration approval.

All three hope to bring to the market the first weight loss treatment in some 13 years.

To continue reading, please click here…

With or Without "Obamacare" These Healthcare Stocks Are Headed Higher

The fat lady hasn't sung yet…but she is warming up.

Three days of arguments before the Supreme Court have made it abundantly clear – "Obamacare" is in danger of being gutted or completely wiped off the books.

Only one thing's for sure. Investors will want to keep buying healthcare stocks -especially as 10,000 baby boomers a day turn 65 years old for the next 20 years.

But there's one segment of the healthcare sector that will be sitting in the driver's seat when it comes to delivering healthy profits and investment returns – no matter how the court rules.

Here's what you need to know…

To continue reading, please click here…

Health Care Reform: How the Supreme Court's Affordable Care Act Ruling Could Affect Our Economy

Health care reform takes center stage this week as the U.S. Supreme Court hears arguments on the constitutionality of the Affordable Care Act, otherwise known as Obamacare – and it's going to be a real doozy.

A final decision will be issued around the end of June, just months before the presidential election. It could be like the shot heard "round the world.

Law, politics, U.S. world image, and our economy weigh in the balance.

Pundits are predicting and cogs are turning. Here's how the Supreme Court's decision on Obamacare may play out and how it might affect our economy.

To continue reading, please click here…

Congressional Spat Over Doctor's Medicare Pay Threatens Obama's Healthcare Reform Effort

A Congressional stalemate over how to stave off a hefty pay cut to doctors treating Medicare patients threatens to undermine President Barack Obama's healthcare reform effort – even as the administration mails out a glossy brochure to reassure seniors the healthcare program is on solid ground. For the third time this year, Democrats and Republicans [...]

Question of the Week: Do the Pitfalls Outweigh the Promise For the New Healthcare Reform Program?

[Editor's Note: We were surprised and pleased with the number of responses we received to the inaugural installment of our new "Money Morning Question of the Week" feature. The responses were noteworthy for their insights, and the passion with which the views were presented. Make sure to check out next week's question. Let your "vote" be heard.]

When U.S. President Barack Obama signed the new healthcare-reform bill into law yesterday (Tuesday), it ended months of political bickering and maneuvering, and began a new chapter in the nation's healthcare saga – one in which the country will feel the effects of this sweeping, costly and controversial policy overhaul.

The fact is that many Americans will have healthcare for the first time ever. Offsetting that bright spot, however, is the reality that the program could add trillions in debt to the country's already burgeoning national debt, further complicating the matter.

Going forward, it will now be left to the pundits, analysts and the healthcare industry to decipher what these provisions really mean for the industry, for individuals, for taxpayers – and even for investors.

But here at Money Morning, we wanted to know what you think about this new law. That's why we made healthcare reform the inaugural topic in our new "Question of the Week" feature.

Money Morning Question of the Week: U.S. President Barack Obama's controversial healthcare proposal is now law. What do you think? How do you feel? Do you think it's a beneficial or harmful move for you as a consumer, as an investor, and as a taxpayer? What do you think it means for our nation's economy?

What follows is a sampling of the enthusiastic and passionate responses that we received. Make sure to also check out next week's "Question of the Week," a query that seeks your thoughts on the growing levels of U.S. debt.

Healthcare Reform Losers: Companies Providing Retiree Benefits Face Multi-Million Dollar Tax Costs

After sending letters of protest to Congress in the months prior to the healthcare law's approval, U.S. companies are now facing multi-million dollar after-tax hits this year due to a tax provision in the new legislation, labeling them healthcare reform losers instead of winners.

Part of the new healthcare law places a federal income tax on government subsidies given to companies that provide retirees and their spouses with drug benefit plans. The 28% subsidy was created as Medicare Part D, adding a prescription plan for senior citizens to the Medicare Act of 2003. To encourage companies to continue offering retirees a drug plan, the tax-free subsidy reduced companies' costs. Fewer senior citizens then went through Medicare's prescription program – which would have cost taxpayers much more than the subsidy price.

Caterpillar Inc (NYSE: CAT) and Deere & Company (NSYE: DE) are just two of the businesses that fought the new stipulations. The manufacturers estimate the tax will cost them $100 million and $150 million this year, respectively. Other companies who will pay handsomely include AK Steel Corp. (NYSE: AKS) with $31 million in charges, and Honeywell International Inc. (NYSE: HON) with an estimated fee of $42 million.

Consulting firm Towers Watson & Co. (NYSE: TW) estimates these taxes could cost companies about $233 per person receiving drug benefits – a hefty price tag when a company gives benefits to 40,000 retirees, like Caterpillar.

Overall, more than 3,500 companies offer drug benefits to 6.3 million retirees. Although the tax won't be effective until 2011, accounting practices force companies to recognize the fees in the period in which the law is signed. That means the tax could nab $14 billion from corporate profits in a year when companies were hoping to recover from huge losses during the recession.

We Want to Hear From You: What Do You Think About the New Healthcare Law?

After months of controversy, political bickering and maneuvering, and intense media speculation and scrutiny, this week became a historically significant moment in the annals of U.S. healthcare when U.S. President Barack Obama signed the new healthcare bill into law. Thus begins a new chapter in the healthcare saga, when the country will feel the effects [...]

Drug Companies and Hospitals Get a Boost from Healthcare Reform

After months of trying to predict how the healthcare reform proposals would affect the respective futures of their industries, drug companies and hospitals are optimistic about the prospective long-term profits the final version of the health care reform bill could bring them.

President Barack Obama yesterday (Tuesday) signed the $940 billion health care reform bill with support from pharmaceutical companies and the hospital industry. Both will benefit from a sharp increase in the number of insured customers, as the bill expands healthcare to up to 32 million more people.

While the bill will cost tens of billions of dollars over the next 10 years, the planned reforms create something drug companies and hospitals can't live without: paying consumers.

Shaky CBO Deficit Projections Help Healthcare Reform Bill Pass House

When the comprehensive healthcare reform bill won approval from the House on Sunday, some of the swing lawmakers were won over by a new Congressional Budget Office (CBO) analysis showing the bill will slash the deficit by over $1.3 trillion over the next 20 years.

But at a time when the U.S. budget is already saddled with hefty doses of red ink, there's a growing debate about whether the new bill will reduce the deficit or evolve into another entitlement program that will expand the country's debt beyond already record levels.

Even though the bill – which President Barack Obama has hailed as the "most significant effort to reduce the deficit since the Balanced Budget Act" of the 1990s – will cost the federal government $940 billion over a ten-year period, the CBO said it will increase revenue and cut other costs by an even greater amount.

Show me